Taro Pharmaceutical Industries (TARO) to Release Quarterly Earnings on Wednesday

Taro Pharmaceutical Industries (NYSE:TARO) will be issuing its quarterly earnings data after the market closes on Wednesday, May 22nd. Analysts expect the company to announce earnings of $2.26 per share for the quarter.

Taro Pharmaceutical Industries stock opened at $101.34 on Friday. Taro Pharmaceutical Industries has a 52 week low of $76.93 and a 52 week high of $121.23. The firm has a market cap of $4.02 billion, a PE ratio of 16.40 and a beta of 0.51.

Several analysts have recently commented on the stock. Zacks Investment Research cut shares of Taro Pharmaceutical Industries from a “buy” rating to a “hold” rating in a research note on Wednesday, April 3rd. TheStreet upgraded shares of Taro Pharmaceutical Industries from a “c” rating to a “b-” rating in a research note on Friday, February 15th.



A hedge fund recently raised its stake in Taro Pharmaceutical Industries stock. Geode Capital Management LLC raised its holdings in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by 124.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,255 shares of the company’s stock after buying an additional 4,018 shares during the period. Geode Capital Management LLC’s holdings in Taro Pharmaceutical Industries were worth $613,000 at the end of the most recent reporting period. Institutional investors own 10.16% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Taro Pharmaceutical Industries (TARO) to Release Quarterly Earnings on Wednesday” was reported by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://dakotafinancialnews.com/2019/05/17/taro-pharmaceutical-industries-taro-to-release-quarterly-earnings-on-wednesday.html.

About Taro Pharmaceutical Industries

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories.

Recommended Story: Equity Income

Earnings History for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.